Preterm Birth and PROM Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION
Preterm Birth and PROM (Premature rupture of membranes) is the rupture of fetal membranes that occurs before 37 weeks' gestation. This may be caused by natural weakening of the membrane or from the forces of the contraction or due to an infection in the uterus.

MARKET DYNAMICS
The Preterm Birth and PROM Testing market is anticipated to grow in the forecast, owing to the factors such as rising number of preterm births, increasing average woman being pregnant with diseases like diabetes and high blood pressure, growing demand for point-of-care testing devices and rise in demand for cost effective diagnostic tests. Nevertheless, lack of awareness about new technologies and use of alternative diagnostic such as transvaginal scan etc. are expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Preterm Birth and PROM Testing Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Preterm Birth and PROM Testing market with detailed market segmentation by Test Type, end user and geography. The global Preterm Birth and PROM Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Preterm Birth and PROM Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Preterm Birth and PROM Testing market is segmented on the basis of Test Type and End User. Based on Test type the market is segmented into Preterm Birth Test and PROM tests. Preterm Birth tests is further sub segmented into Pelvic Exam, Ultrasound, Uterine Monitoring, Biomarkers. PROM test is further sub segmented into Nitrazine Test, Ferning Test, Pooling, Ultrasound, Fetal Fibronectin Test, Biomarkers and Others. Based on End User the market is segmented into Hospitals, Diagnostic Laboratories. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Preterm Birth and PROM Testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Preterm Birth and PROM Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Preterm Birth and PROM Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Preterm Birth and PROM Testing market in these regions.

Preterm Birth and PROM Testing Market Report Analysis

Preterm Birth and PROM Testing Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• QIAGEN
• Hologic, Inc
• Medix Biochemica
• Biosynex
• Abbott Laboratories
• Clinical Innovations, LLC
• Sera Prognostics, Inc
• The Cooper Companies, Inc
• NX Prenatal, Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Test Type

• Preterm Birth Test
• PROM tests

By End User

• Hospitals
• Diagnostic Laboratories

MARKET PLAYERS
The reports cover key developments in the Preterm Birth and PROM Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Preterm Birth and PROM Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Preterm Birth and PROM Testing market in the global market. Below mentioned is the list of few companies engaged in the Preterm Birth and PROM Testing market.

The report also includes the profiles of Preterm Birth and PROM Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• QIAGEN
• Hologic, Inc
• Medix Biochemica
• Biosynex
• Abbott Laboratories
• Clinical Innovations, LLC
• Sera Prognostics, Inc
• The Cooper Companies, Inc
• NX Prenatal, Inc
• IQ Products

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Preterm Birth and PROM Testing Market Report Scope